James M Frates - Net Worth and Insider Trading
James M Frates Net Worth
The estimated net worth of James M Frates is at least $5 Million dollars as of 2024-04-25. James M Frates is the SVP, Alks Inc; CFO ALKS of Alkermes PLC and owns about 183,438 shares of Alkermes PLC (ALKS) stock worth over $4 Million. James M Frates is the CFO of Amylyx Pharmaceuticals Inc and owns about 145,856 shares of Amylyx Pharmaceuticals Inc (AMLX) stock worth over $259,624. James M Frates is also the Director of Sage Therapeutics Inc and owns about 2,845 shares of Sage Therapeutics Inc (SAGE) stock worth over $38,635. Details can be seen in James M Frates's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James M Frates has not made any transactions after 2024-03-05 and currently still holds the listed stock(s).
Transaction Summary of James M Frates
James M Frates Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James M Frates owns 3 companies in total, including Sage Therapeutics Inc (SAGE) , Alkermes PLC (ALKS) , and Amylyx Pharmaceuticals Inc (AMLX) .
Click here to see the complete history of James M Frates’s form 4 insider trades.
Insider Ownership Summary of James M Frates
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SAGE | Sage Therapeutics Inc | 2021-06-16 | director |
| ALKS | Alkermes PLC | 2018-06-12 | SVP & CFO & Alkermes plc |
| AMLX | Amylyx Pharmaceuticals Inc | 2024-03-05 | Chief Financial Officer |
James M Frates Latest Holdings Summary
James M Frates currently owns a total of 3 stocks. Among these stocks, James M Frates owns 183,438 shares of Alkermes PLC (ALKS) as of June 12, 2018, with a value of $4 Million and a weighting of 93.76%. James M Frates owns 145,856 shares of Amylyx Pharmaceuticals Inc (AMLX) as of March 5, 2024, with a value of $259,624 and a weighting of 5.43%. James M Frates also owns 2,845 shares of Sage Therapeutics Inc (SAGE) as of June 16, 2021, with a value of $38,635 and a weighting of 0.81%.
Latest Holdings of James M Frates
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALKS | Alkermes PLC | 2018-06-12 | 183,438 | 24.44 | 4,483,225 |
| AMLX | Amylyx Pharmaceuticals Inc | 2024-03-05 | 145,856 | 1.78 | 259,624 |
| SAGE | Sage Therapeutics Inc | 2021-06-16 | 2,845 | 13.58 | 38,635 |
Holding Weightings of James M Frates
James M Frates Form 4 Trading Tracker
According to the SEC Form 4 filings, James M Frates has made a total of 0 transactions in Alkermes PLC (ALKS) over the past 5 years. The most-recent trade in Alkermes PLC is the sale of 16,842 shares on June 12, 2018, which brought James M Frates around $842,100.
According to the SEC Form 4 filings, James M Frates has made a total of 6 transactions in Amylyx Pharmaceuticals Inc (AMLX) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Amylyx Pharmaceuticals Inc is the sale of 1,792 shares on March 5, 2024, which brought James M Frates around $33,564.
According to the SEC Form 4 filings, James M Frates has made a total of 3 transactions in Sage Therapeutics Inc (SAGE) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Sage Therapeutics Inc is the acquisition of 1,810 shares on June 16, 2021, which cost James M Frates around $99,731.
Insider Trading History of James M Frates
- 1
James M Frates Trading Performance
GuruFocus tracks the stock performance after each of James M Frates's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James M Frates is -17.46%. GuruFocus also compares James M Frates's trading performance to market benchmark return within the same time period. The performance of stocks bought by James M Frates within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James M Frates's insider trading performs compared to the benchmark.
Performance of James M Frates
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -13.01 | -17.46 | -29.06 | -42.86 | 0.32 | |
| Relative Return to S&P 500(%) | -15.46 | -23.38 | -39.6 | -29.67 | -1.86 |
James M Frates Ownership Network
Ownership Network List of James M Frates
Ownership Network Relation of James M Frates
James M Frates Owned Company Details
What does Sage Therapeutics Inc do?
Who are the key executives at Sage Therapeutics Inc?
James M Frates is the director of Sage Therapeutics Inc. Other key executives at Sage Therapeutics Inc include director & See Remarks Jeffrey M Jonas , Chief Medical Officer Laura Gault , and Chief Commercial Officer Christopher Benecchi .
Sage Therapeutics Inc (SAGE) Insider Trades Summary
Over the past 18 months, James M Frates made no insider transaction in Sage Therapeutics Inc (SAGE). Other recent insider transactions involving Sage Therapeutics Inc (SAGE) include a net purchase of 3,000 shares made by Elizabeth Barrett , a net purchase of 14,500 shares made by Barry E Greene , and a net sale of 11,643 shares made by Jeffrey M Jonas .
In summary, during the past 3 months, insiders sold 0 shares of Sage Therapeutics Inc (SAGE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,643 shares of Sage Therapeutics Inc (SAGE) were sold and 17,500 shares were bought by its insiders, resulting in a net purchase of 5,857 shares.
Sage Therapeutics Inc (SAGE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sage Therapeutics Inc Insider Transactions
James M Frates Mailing Address
Above is the net worth, insider trading, and ownership report for James M Frates. You might contact James M Frates via mailing address: 88 Sidney St, Cambridge Ma 021394136.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
